Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women

  • Ngamkham, Jarunya (Department of Research and Technology Assessment, National Cancer Institute) ;
  • Boonmark, Krittika (Department of Research and Technology Assessment, National Cancer Institute) ;
  • Phansri, Thainsang (Department of Research and Technology Assessment, National Cancer Institute)
  • Published : 2016.04.11
Download PDF
⟨ Previous Next ⟩

Abstract

Vulva and Vaginal cancers are rare among all gynecological cancers worldwide, including Thailand, and typically affect women in later life. Persistent high risk human papillomavirus (HR-HPV) infection is one of several important causes of cancer development. In this study, we focused on HPV investigation and specific type distribution from Thai women with abnormality lesions and cancers of the vulva and Vaginal. A total of ninety paraffin-embedded samples of vulva and Vaginal abnormalities and cancer cells with histologically confirmed were collected from Thai women, who were diagnosed in 2003-2012 at the National Cancer Institute, Thailand. HPV DNA was detected and genotyped using polymerase chain reaction and enzyme immunoassay with GP5+/bio 6+ consensus specific primers and digoxigenin-labeled specific oligoprobes, respectively. The human ${\beta}$-globin gene was used as an internal control. Overall results represented that HPV frequency was 16/34 (47.1%) and 8/20 (40.0%) samples of vulva with cancer and abnormal cytology lesions, respectively, while, 3/5 (60%) and 16/33 (51.61%) samples of Vaginal cancer and abnormal cytology lesions, respectively, were HPV DNA positive. Single HPV type and multiple HPV type infection could be observed in both type of cancers and abnormal lesion samples in the different histological categorizes. HPV16 was the most frequent type in all cancers and abnormal cytology lesions, whereas HPV 18 was less frequent and could be detected as co-infection with other high risk HPV types. In addition, low risk types such as HPV 6, 11 and 70 could be detected in Vulva cancer and abnormal cytology lesion samples, whereas, all Vaginal cancer samples exhibited only high risk HPV types; HPV 16 and 31. In conclusion, from our results in this study we suggest that women with persistent high risk HPV type infection are at risk of developing vulva and Vaginal cancers and HPV 16 was observed at the highest frequent both of these, similar to the cervical cancer cases. Although the number of samples in this study was limited and might not represent the overall incidence and prevalence in Thai women, but the baseline data are of interest and suggest further study for primary cancer screening and/or developing the efficiency of prophylactic HPV vaccines in Thailand.

Keywords

References

  1. Baldez da Silva MF, Guimaraes V, Silva MAR, et al (2012). Frequency of human papillomavirus type 16, 18,31 and 33 and site of cervical lesions in gynecological patients from Recife, Brazil. Genet Mol Res, 11, 462-6. https://doi.org/10.4238/2012.March.1.3
  2. Bharti AC, Shukla S, Mahata S et al, (2010). Human papillomavirus and control of cervical cancer in India. Expert Rev Obstet Gynnecol, 5, 329-46. https://doi.org/10.1586/eog.10.23
  3. Chaturvedi AK (2010). Beyond cervical cancer: burden of other HPV-related cancer among men and women. J Adolesc Health, 46, 20-6.
  4. de Martel C, Ferlay J, Franceschi S, et al (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis, Lancet Oncol, 13, 607-15. https://doi.org/10.1016/S1470-2045(12)70137-7
  5. de Villiers EM (2001). Taxonomic classification of papillomavirus. Papillomavirus Rep, 12, 57-67.
  6. de Villiers EM, Fauquet C, Broker TR, et al (2004). Classification of papillomaviruses. Virol, 324, 17-27. https://doi.org/10.1016/j.virol.2004.03.033
  7. De Vuyst H, Clifford GM, Nascimento MC, et al (2009). Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, Vaginal and anal: a meta-analysis. Int J Cancer, 124, 1626-36. https://doi.org/10.1002/ijc.24116
  8. Dittmer C, Katalinic A, Mundhenke C, et al (2011). Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet, 284, 169-74. https://doi.org/10.1007/s00404-011-1850-9
  9. Ganguly N (2012). Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value. Cell Oncol, 35, 67-76. https://doi.org/10.1007/s13402-011-0069-x
  10. Gao W, Weng J, Ga Y et al (2013). Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-section study, BMC Infectious Diseases, 13, 271 (open access). https://doi.org/10.1186/1471-2334-13-271
  11. Gillison ML, Shah KV (2003). Chapter 9: Role of Mucosal Human Papillomavirus in Nongenital Cancers, J Natl Cancer Inst Monogr, 31, 57-65.
  12. Hampl M, Sarajuuri H, Wentzensen N, et al (2006). Effect of human papillomavirus vaccines on vulvar, vaginal and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol, 108, 1361-8. https://doi.org/10.1097/01.AOG.0000245786.86267.80
  13. Hampl M, Wentzensen N, Vinokurova S, et al (2007). Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile. J Cancer Res Clin Oncol, 133, 235-45. https://doi.org/10.1007/s00432-006-0162-0
  14. ICO Information Center on HPV and Cancer (HPV Information Center) (2014). Human Papillomavirus and Related Diseases Report.
  15. Jacob MV, van der Brule AJ, Snijder PJ, et al (1996). A non-radioactive PCR enzyme-Immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR. J Med Virol, 49, 223-9. https://doi.org/10.1002/(SICI)1096-9071(199607)49:3<223::AID-JMV11>3.0.CO;2-D
  16. Jacob MV, van der Brule, Snijder PJ, et al (1997). A general primer GP5+/6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol, 35, 791-5.
  17. Jacob MV, Walboomers JM, Snijder PJ, et al (2000). Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related pattern for high-risk and low-risk types. Int J Cancer, 87, 221-7. https://doi.org/10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2
  18. Karunaratne K (2011). Review: squamous cell vulva cancer. Sri Lanka J Obstet Gynecol, 33, 30-2.
  19. Khuhaprema T, Attasara P Sriplung H, et al (2013). Cancer in Thailand Vol VII 2007-2008, Bangkok, Thailand.
  20. Madeleine MM, Daling JR, Carter JJ, et al (1997). Cofactor with human papillomavirus in a population-based study of vulva cancer. J Natl Cancer Inst, 39, 1516-23.
  21. Moody CA, Laimins LA (2010). Human papillomavirus oncoproteins pathways to transformation. Nature Reviews, 10, 550-60.
  22. Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl Med, 348, 518-27. https://doi.org/10.1056/NEJMoa021641
  23. Munoz N, Castellsague X, de Gonzalez AB, et al (2006). Chapter I: HPV in the etiology of human cancer vaccine, 24, 1-10. https://doi.org/10.1016/j.vaccine.2005.07.047
  24. Ngamkham J, Homcha-aim P, Boonmark K, et al (2013). Preliminary study on human papillomavirus frequency and specific type-distribution in vulva cancer from thai women. Asian Pac J Cancer Prev, 14, 2355-9. https://doi.org/10.7314/APJCP.2013.14.4.2355
  25. Parkin DM (2006). The global health burden of infection associated cancer in the year 2002. Int J Cancer, 118, 3030-44. https://doi.org/10.1002/ijc.21731
  26. Ramet J, van Esso D, Meszner Z, et al (2010). Position paper-HPV and the primary prevention of cancer, improving vaccine uptake by paediatricians. Eur J Pediatr, 170, 309-21.
  27. Sankaranarayanan R, Feray J (2006). Worldwide burden of gynecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol, 20, 207-25. https://doi.org/10.1016/j.bpobgyn.2005.10.007
  28. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesion: a meta-analysis update. Int J Cancer, 121, 621-2. https://doi.org/10.1002/ijc.22527
  29. Terlou A, Blok LJ, Helmerhorst TJM, et al (2010). Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ. Acta Obstet Gynecol, 89, 741-48. https://doi.org/10.3109/00016341003739575
  30. Trimble CL, Hildesheim A, Brinton LA, et al (1996). Heterogeneous etiology of squamous carcinoma of the vulva.

Cited by

  1. Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis vol.13, pp.9, 2018, https://doi.org/10.1371/journal.pone.0204162